Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Analysts at Seaport Res Ptn lifted their Q4 2025 earnings per share (EPS) estimates for Jushi in a note issued to investors on Sunday, August 10th. Seaport Res Ptn analyst S. Randhawa now expects that the company will earn ($0.05) per share for the quarter, up from their prior forecast of ($0.06). The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Seaport Res Ptn also issued estimates for Jushi's Q2 2026 earnings at ($0.04) EPS and FY2026 earnings at ($0.19) EPS.
Jushi Stock Down 14.7%
Shares of OTCMKTS:JUSHF opened at $0.68 on Wednesday. The company's fifty day moving average is $0.41 and its two-hundred day moving average is $0.35. Jushi has a 12-month low of $0.22 and a 12-month high of $0.98. The company has a market cap of $134.12 million, a P/E ratio of -2.35 and a beta of -0.98.
Jushi (OTCMKTS:JUSHF - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.06) EPS for the quarter, meeting analysts' consensus estimates of ($0.06). The company had revenue of $65.05 million for the quarter, compared to analyst estimates of $64.67 million.
About Jushi
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access